Certest – VIASURE Monkeypox Real-Time PCR Detection Kit
Monkeypox is on the rise by using Certest’s VIASURE Monkeypox Real-Time PCR Detection Kit* you can accurately detect the monkeypox clade II and the novel monkeypox clade I.
19Dec
News
19Dec
Certest – VIASURE Real-Time PCR Detection Kits
Certest’s VIASURE Real-Time Polymerase Chain Reaction (PCR) Detection kits are designed for the isolation and purification of viral, bacterial, parasitic, and fungal DNA and RNA from different clinical samples.
21Mar
Devyser LynchFAP NGS
THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC.
Devyser LynchFAP1 is the first kit on the market to accurately assess all PMS2 variants!
First commercial kit to include a long-range PCR to unambiguously determine variants in all PMS2 exons.
12Feb
New VIRCELL AMPLIRUN® SARS-CoV-2 B.1.1.7 RNA CONTROL
Products are for professional/laboratory use only. We are pleased to announce the launch of the new Vircell AmpliRun® that contains the purified RNA of SARS-CoV-2 B.1.1.7 lineage, also known as VOC 202012/01 or UK variant, to be used as a control in nucleic acid amplification-based techniques.
New Vircell Transport Medium
Products are for professional/laboratory use only. We are happy to announce the launch of new Vircell Transport Medium (TM) for the collection and preservation of viruses.
Molecular QC for SARS CoV2 + Flu + RSV
Products are for professional/laboratory use only.
AccuPlex™ Reference Material Kits are designed to measure day-to-day performance of the assay, providing both a positive and a negative reference solution.
03Feb
Idylla™ ctNRAS-BRAF-EGFR S492R Mutation Assay (Research Use Only)
Products are for professional/laboratory use only.
Being the third¹ liquid biopsy test for Biocartis, the Idylla™ ctNRAS-BRAF-EGFR S492R Mutation Assay (Research Use Only), also marks an important milestone in the partnership with the leading science and technology company Merck².
03Feb
Study using Biocartis’ liquid biopsy BRAF assay shows new option for retreatment of melanoma patients
Products are for professional/laboratory use only.
Biocartis is pleased to announce the publication of an important study [1] by Prof. Dr. Bart Neyns from the University Hospital in Brussels (Belgium) in the clinical oncology journal The Lancet Oncology: ‘A second chance for success with BRAF and MEK inhibitors in Melanoma’.
03Feb
Discover Idylla Explore – offering insight into your molecular data
Products are for professional/laboratory use only.
Get connected and enjoy the advantages of Idylla Explore, a web-based application that allows you to analyze your data by providing: